Amgen After ASCO: Questions Remain On Lumakras, Bemarituzumab

 
• By Mandy Jackson
  
Lung cancer; wooden puzzle on dark surface
Questions about Lumakras in KRAS G12C-mutated lung cancer with co-mutations may be answered in Phase III • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from ASCO

More from Conferences